
Innovaccer
Total Raised
$650.68MInvestors Count
34Deal Terms
5Funding, Valuation & Revenue
14 Fundings
Innovaccer has raised $650.68M over 14 rounds.
Innovaccer's latest funding round was a Secondary Market for on January 9, 2025.
Innovaccer's valuation in January 2025 was $3,175 - $3,450M.
Innovaccer's latest post-money valuation is from January 2025.
Sign up for a free demo to see Innovaccer's valuations in December 2021, February 2021 and more.
Innovaccer's 2024 revenue was $150T. Innovaccer's most recent revenue is from 2021.
Sign up for a free demo to see revenue data from 2024, 2021 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
1/9/2025 | Secondary Market | 3 | ||||
1/9/2025 | Series F | $275M | $3,175 - $3,450M | 8 | ||
1/1/2025 | Shareholder Liquidity | $150T FY 2024 | 3 | |||
12/15/2021 | Series E | |||||
2/19/2021 | Series D |
Date | 1/9/2025 | 1/9/2025 | 1/1/2025 | 12/15/2021 | 2/19/2021 |
---|---|---|---|---|---|
Round | Secondary Market | Series F | Shareholder Liquidity | Series E | Series D |
Amount | $275M | ||||
Investors | |||||
Valuation | $3,175 - $3,450M | ||||
Revenue | $150T FY 2024 | ||||
Sources | 3 | 8 | 3 |
Innovaccer Deal Terms
5 Deal Terms
Innovaccer's deal structure is available for 5 funding rounds, including their Series F from January 09, 2025.
Round | Series F | Series E | Series D | Series B | Series A |
---|---|---|---|---|---|
Funding Date | |||||
Pre-Money Valuation | |||||
Post-Money Valuation | |||||
Amount Raised | |||||
Shares Authorized | |||||
Issuance Price | |||||
Dividend Rate | |||||
Liquidation Preferences | |||||
Liquidation Price | |||||
Participation | |||||
Conversion Price | |||||
Anti Dilution | |||||
General Voting | |||||
Board Voting | |||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series F | |||||||||||||||
Series E | |||||||||||||||
Series D | |||||||||||||||
Series B | |||||||||||||||
Series A |
Innovaccer Investors
34 Investors
Innovaccer has 34 investors. M12 invested in Innovaccer's Secondary Market funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
3/2/2018 | 1/9/2025 | 8 Series B, Series B - II (2019), Series C (2019), Series C - II (2020), Series D (2021), Series E (2021), Series F (2025), Secondary Market (2025) | Corporate Venture | Washington | ||
2/19/2021 | 1/9/2025 | 4 Series D, Series E (2021), Series F (2025), Secondary Market (2025) | Venture Capital | California | ||
1/9/2025 | 1/9/2025 | 2 Series F, Secondary Market (2025) | Asset/Investment Management | United Kingdom | ||
Corporation | California | |||||
Corporate Venture | Washington |
First funding | 3/2/2018 | 2/19/2021 | 1/9/2025 | ||
---|---|---|---|---|---|
Last Funding | 1/9/2025 | 1/9/2025 | 1/9/2025 | ||
Investor | |||||
Rounds | 8 Series B, Series B - II (2019), Series C (2019), Series C - II (2020), Series D (2021), Series E (2021), Series F (2025), Secondary Market (2025) | 4 Series D, Series E (2021), Series F (2025), Secondary Market (2025) | 2 Series F, Secondary Market (2025) | ||
Board Seats | |||||
Type | Corporate Venture | Venture Capital | Asset/Investment Management | Corporation | Corporate Venture |
Location | Washington | California | United Kingdom | California | Washington |
Innovaccer Acquisitions
4 Acquisitions
Innovaccer acquired 4 companies. Their latest acquisition was Story Health on September 16, 2025.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
9/16/2025 | Series A | $26.6M | Acquired | 2 | ||
1/21/2025 | ||||||
3/12/2024 | ||||||
1/16/2024 | Series A |
Date | 9/16/2025 | 1/21/2025 | 3/12/2024 | 1/16/2024 |
---|---|---|---|---|
Investment Stage | Series A | Series A | ||
Companies | ||||
Valuation | ||||
Total Funding | $26.6M | |||
Note | Acquired | |||
Sources | 2 |
Compare Innovaccer to Competitors
CareMoat is a platform that provides data analytics-driven predictive modeling to offer insights for self-funded employers within the healthcare industry. The company assigns Nurse Champions to support employees and facilitates an application for health benefit management. CareMoat serves the self-insured employer sector, focusing on improving healthcare experiences and reducing costs. It was founded in 2019 and is based in Nashville, Tennessee.

Clinithink is a technology company specializing in artificial intelligence for the life sciences and healthcare sectors. The company offers AI solutions that analyze unstructured healthcare data. Clinithink serves the pharmaceutical and healthcare industries with its AI technology aimed at enhancing clinical trial processes, disease diagnosis, and revenue management. It was founded in 2009 and is based in Bridgend, United Kingdom.

Arcadia focuses on big data technology within the healthcare sector. It provides services such as data aggregation, analytics tools, and applications. It serves healthcare providers, payers, and government entities with an emphasis on population health management, care coordination, and decision-making based on data. It was founded in 2002 and is based in Boston, Massachusetts.

Optum operates as a health solution and care delivery organization that provides health care services, financial health accounts, and pharmacy benefits management. The company offers care, financial tools for health expenses, and pharmacy services, including home delivery and specialty medications. Optum serves individuals and families, providers and organizations, employers, brokers, and consultants within the health care, financial, and pharmacy sectors. It was founded in 2011 and is based in Eden Prairie, Minnesota.

NextGen Healthcare offers integrated health information technology (IT) solutions and data analytics in the healthcare sector. The company has cloud-based electronic health records (EHR) and practice management (PM) software, as well as interoperability, patient engagement, revenue cycle management, and value-based care analytics. NextGen Healthcare serves mid-size to enterprise practices and small practices with specialty-specific content and services. NextGen Healthcare was formerly known as NXGN Management. It was founded in 1974 and is based in Irvine, California.

Applied Research Works provides a cloud-based platform for data analytics in quality, cost, and risk management for healthcare organizations. The company's solutions aim to support payers, provider organizations, and healthcare partners. It was founded in 2012 and is based in San Ramon, California.
Loading...